Furthermore, circulating TMAO induces low-grade chronic systemic inflammation [34] and increases levels of inflammatory cytokines by promoting NF-κB activation [35] and activating the NLRP3 inflammasome [26]. The gene discussed is NFKB1; the disease is inflammatory response.